NEW YORK, NY—A systematic program designed to close the diagnosis and treatment gaps for patients with aortic stenosis (AS) ...
NEW YORK, NY—Patients who undergo mitral transcatheter edge-to-edge repair (M-TEER) for symptomatic severe mitral ...
Data from VIRGO and NHANES linked early menarche, age at first birth, and other factors to risk of early-onset acute MI.
M-TEER With PASCAL for Cardiogenic Shock Secondary to Acute Papillary Muscle Rupture Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Juan Granada and Nicolas Van Mieghem share an overview of the data presented on day 2 of NY Valves.
Primary results of the ENCIRCLE trial led to approval of the M3 device by the US Food and Drug Administration as the first ...
“TAVR with the Sapien 3 platform demonstrated comparable 7-year durability to surgery, supporting its use as a treatment option in lifetime management of low-risk patients with symptomatic severe AS,” ...
While the dataset is incomplete, the death and stroke curves appear to separate at 2 years, notes Philippe Généreux.
Cardiovascular surgery seems to be just as safe in patients with concomitant multiple sclerosis (MS) as in those without the ...
The TCTMD journalists talk about 10-year TAVI data, a FLOW subanalysis, and women's heart centers in Europe. NY Valves ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results